Two newly published studies link a rise in serious bleeding among infants in the United States to more parents declining the vitamin K shot given to newborns, according to The Washington Post. The New York Times, Reuters, ABC News and Bloomberg all reported on the findings, with Bloomberg describing a rise in infant deaths following parental refusals.
The injection is offered shortly after birth to protect babies from vitamin K deficiency bleeding, a rare but potentially life-threatening condition in early infancy. The studies, as summarized in the reporting, found that bleeding episodes increased last year as refusal rates climbed.
The scale of the shift, the specific number of cases, and the design of the research were not detailed in the available material. The Washington Post's headline frames the trend around parents refusing the shot, while Reuters describes the evidence as coming from two separate studies.
Coverage across the outlets was consistent in its central finding: fewer newborns are receiving the injection, and bleeding cases have moved in the opposite direction. The reporting does not, in the material available, identify which regions or hospitals were most affected.
What to watch next: whether health authorities or pediatric bodies respond to the studies with updated guidance on the vitamin K injection, and whether refusal rates continue to rise in subsequent data.
